Search research articles
Contact Us
Filters
Showing results (11-20 of 93) with videos related to
Page
of 10
Sort By:
Immunotherapy
|
January 20, 2026
Dual-edged therapy: corticosteroids in the era of immunotherapy
Angelina Lim, Robert Hsu, Jorge Nieva, et al.
AJR. American Journal of Roentgenology
|
January 9, 2019
Radiomics in Pulmonary Lesion Imaging
Cameron Hassani, Bino A Varghese, Jorge Nieva, et al.
Frontiers in Oncology
|
May 12, 2020
A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs
Elizabeth Pan, David Bogumil, Victoria Cortessis, et al.
Current Opinion in Virology
|
May 20, 2015
Oncolytic viruses: perspectives on clinical development
James Burke, Jorge Nieva, Mitesh J Borad, et al.
Research Square
|
November 1, 2024
Assessing platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: An analysis across TKI generations
Ryan Cooper, Dhruv Ramaswami, Jacob Thomas, et al.
JTO Clinical and Research Reports
|
August 7, 2023
Response to Letter to the Editor Titled "Seize the Opportunity With Small Tissue Samples: The Tailor Teaches!"
Ching-Fei Chang, Raymond Diep, Madeline MacDonald, et al.
Drugs - Real World Outcomes
|
June 6, 2022
Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data
Jorge Nieva, Karen L Reckamp, Danielle Potter, et al.
Thrombosis Research
|
February 12, 2008
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients
Rachel E Tilley, Todd Holscher, Rajesh Belani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 17, 2014
Adrenal metastases in lung cancer: clinical implications of a mathematical model
Lyudmila Bazhenova, Paul Newton, Jeremy Mason, et al.
Immunology Letters
|
January 3, 2006
Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway
Jorge Nieva, Lisa Kerwin, Anita D Wentworth, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 93) with videos related to
Sort By:
Page
of 10
Immunotherapy
|
January 20, 2026
Dual-edged therapy: corticosteroids in the era of immunotherapy
Angelina Lim, Robert Hsu, Jorge Nieva, et al.
AJR. American Journal of Roentgenology
|
January 9, 2019
Radiomics in Pulmonary Lesion Imaging
Cameron Hassani, Bino A Varghese, Jorge Nieva, et al.
Frontiers in Oncology
|
May 12, 2020
A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs
Elizabeth Pan, David Bogumil, Victoria Cortessis, et al.
Current Opinion in Virology
|
May 20, 2015
Oncolytic viruses: perspectives on clinical development
James Burke, Jorge Nieva, Mitesh J Borad, et al.
Research Square
|
November 1, 2024
Assessing platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: An analysis across TKI generations
Ryan Cooper, Dhruv Ramaswami, Jacob Thomas, et al.
JTO Clinical and Research Reports
|
August 7, 2023
Response to Letter to the Editor Titled "Seize the Opportunity With Small Tissue Samples: The Tailor Teaches!"
Ching-Fei Chang, Raymond Diep, Madeline MacDonald, et al.
Drugs - Real World Outcomes
|
June 6, 2022
Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data
Jorge Nieva, Karen L Reckamp, Danielle Potter, et al.
Thrombosis Research
|
February 12, 2008
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients
Rachel E Tilley, Todd Holscher, Rajesh Belani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 17, 2014
Adrenal metastases in lung cancer: clinical implications of a mathematical model
Lyudmila Bazhenova, Paul Newton, Jeremy Mason, et al.
Immunology Letters
|
January 3, 2006
Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway
Jorge Nieva, Lisa Kerwin, Anita D Wentworth, et al.
Page
of 10